MedPath

Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Lung Cancer
Interventions
Other: placebo
Biological: Seneca Valley virus-001
Registration Number
NCT01017601
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: A virus called Seneca Valley virus-001 (NTX-010) may be able to kill tumor cells without damaging normal cells. It is not yet known whether NTX-010 is more effective than a placebo in treating small cell lung cancer.

PURPOSE: This randomized phase II trial is studying NTX-010 to see how well it works compared with a placebo when given after chemotherapy in treating patients with extensive-stage small cell lung cancer.

Detailed Description

OBJECTIVES:

Primary

* To compare the progression-free survival (PFS) of patients with extensive-stage small cell lung cancer treated with Seneca Valley virus-001 (NTX-010) vs placebo.

Secondary

* To compare the overall survival (OS) of patients treated with NTX-010 vs placebo.

* To describe the adverse events profile and safety of NTX-010 in this patient population.

* To determine the antitumor response rate, as assessed by RECIST criteria, and duration of tumor response in this patient population.

* To assess the quality of life of this patient population.

Exploratory

* To determine the relationship between the presence of neutralizing antibodies and PFS.

* To assess whether or not a slow viral clearance is associated with better response as determined by PFS.

* To determine any potential impact of the presence of one or several neuroendocrine markers in the tumor sample (synaptophysin, chromogranin, or CD56) on PFS and OS.

* To determine any potential relationship between presence of cell surface determinants of NTX-010 tropism in the tumor tissue and clinical outcomes such as improved PFS and OS.

* To determine any potential relationship between the loss of integrity of IFN signaling in the tumor tissue and clinical outcomes such as improved PFS and OS.

* To assess whether or not the presence of circulating tumor cells permissive to NTX-010 is associated with better clinical outcomes as determined by PFS and OS.

OUTLINE: This is a multicenter study. Patients are stratified according to ECOG performance status (0 vs 1), tumor response to standard chemotherapy (partial response vs stable disease vs complete response), and time between completion of chemotherapy to randomization 1 month (≤1 month) vs 2 months (\>1 month but ≤ 2 months) vs 3 months (\> 2 months but ≤ 3 months). Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive a single dose of Seneca Valley virus-001 (NTX-010) IV over 1 hour on day 1.

* Arm II: Patients receive a single dose of placebo IV over 1 hour on day 1. In both arms, patients may also undergo prophylactic cranial irradiation (PCI) daily on days 22-35 if they have not previously undergone PCI or whole-brain radiotherapy.

Quality of life is assessed at baseline and then periodically during the study.

Blood samples are collected periodically for viral clearance and antiviral neutralizing antibody levels, circulating tumor cells, and other biomarker laboratory studies.

After completion of study therapy, patients are followed up periodically for up to 5 years.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
59
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm IIplaceboPatients receive a single dose of placebo IV over 1 hour on day 1.
Arm ISeneca Valley virus-001Patients receive a single dose of Seneca Valley virus-001 (NTX-010) IV over 1 hour on day 1.
Primary Outcome Measures
NameTimeMethod
Progression-free SurvivalTime from randomization to the disease progression or death (up to 5 years)

The progression-free survival (PFS) was defined as the time from date of randomization to the documentation of disease progression or death as a result of any cause, whichever comes first.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With at Least One Grade 3 or Above Adverse Events Assessed by NCI CTCAE v4.0Up to 23 months

Adverse events were assessed by Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Grading: Grade 1=Mild, Grade 2=Moderate, Grade 3=Severe, Grade 4=Life-threatening, Grade 5=Death. The maximum grade for each type of adverse events were recorded for each patient.

Clinical Significance Change From Baseline to Day 30-59 in the LASA QOLDay 1 Cycle 1 prior to treatment (baseline) and day 30-59 (during the active monitoring phase)

Quality of Life (QOL) was measured using the single-item Linear Analogue Self Assessment (LASA) on a 0-10 scale, with 0=as bad as it can be and 10=as good as it can be. The QOL scores was converted to a 100-point scale, with 0=Low QOL and 100=Best QOL. Change from baseline to day 30-59 was calculated by subtracting the baseline scores from the scores at day 30-59. Clinical Significance change over time was determined by the percentage of patients that report an improvement of more than 10 points on the 0-100 point scale.

Overall SurvivalTime from randomization to death or last follow-up (up to 5 years)

Overall survival was defined as the time from study enrollment (randomization) to the time of death from any cause or last follow-up.

Response Rate (Complete Response and Partial Response) as Assessed by Response Evaluation Criteria in Solid Tumors (RECIST)Up to 5 years

A confirmed tumor response was defined as a complete response (CR) or partial response (PR) noted as the objective status on 2 consecutive evaluations at least 6 weeks apart. Response and progression will be evaluated in this study using the new international criteria proposed by the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1). Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all non-nodal target lesions and each target lymph node must have reduction in short axis to \<1.0 cm.; Partial Response (PR), at least a 30% decrease in the sum of the longest diameters of the non-nodal target lesions and the short axes of the target lymph nodes taking as reference the Baseline Sum of Diameters; Overall Response (OR) = CR + PR.

Duration of ResponseUp to 5 years

Duration of response was defined as the time from the date at which the patient's earliest best objective status was first noted to be either a CR or PR to the earliest date progression was documented.

Change From Baseline to Day 20-29 in the LASA QOLDay 1 Cycle 1 prior to treatment (baseline) and day 20-29 (during the active monitoring phase)

Quality of Life (QOL) was measured using the single-item Linear Analogue Self Assessment (LASA) on a 0-10 scale, with 0=as bad as it can be and 10=as good as it can be. The QOL scores was converted to a 100-point scale, with 0=Low QOL and 100=Best QOL. Change from baseline to day 20-29 was calculated by subtracting the baseline scores from the scores at day 20-29. Negative change indicates the QOL decrease and positive change indicates the QOL improvement.

Change From Baseline to Day 30-59 in the LASA QOLDay 1 Cycle 1 prior to treatment (baseline) and day 30-59 (during the active monitoring phase)

Quality of Life (QOL) was measured using the single-item Linear Analogue Self Assessment (LASA) on a 0-10 scale, with 0=as bad as it can be and 10=as good as it can be. The QOL scores was converted to a 100-point scale, with 0=Low QOL and 100=Best QOL. Change from baseline to day 30-59 was calculated by subtracting the baseline scores from the scores at day 30-59. Negative change indicates the QOL decrease and positive change indicates the QOL improvement.

Clinical Significance Change From Baseline to Day 20-29 in the LASA QOLDay 1 Cycle 1 prior to treatment (baseline) and day 20-29 (during the active monitoring phase)

Quality of Life (QOL) was measured using the single-item Linear Analogue Self Assessment (LASA) on a 0-10 scale, with 0=as bad as it can be and 10=as good as it can be. The QOL scores was converted to a 100-point scale, with 0=Low QOL and 100=Best QOL. Change from baseline to day 20-29 was calculated by subtracting the baseline scores from the scores at day 20-29. Clinical Significance change over time was determined by the percentage of patients that report an improvement of more than 10 points on the 0-100 point scale.

Trial Locations

Locations (196)

El Camino Hospital Cancer Center

🇺🇸

Mountain View, California, United States

George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus

🇺🇸

New Britain, Connecticut, United States

Kalispell Medical Oncology at KRMC

🇺🇸

Kalispell, Montana, United States

Kalispell Regional Medical Center

🇺🇸

Kalispell, Montana, United States

Medcenter One Hospital Cancer Care Center

🇺🇸

Bismarck, North Dakota, United States

St. Alexius Medical Center Cancer Center

🇺🇸

Bismarck, North Dakota, United States

Good Samaritan Cancer Center

🇺🇸

Puyallup, Washington, United States

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Mayo Clinic Scottsdale

🇺🇸

Scottsdale, Arizona, United States

Valley Medical Oncology Consultants - Castro Valley

🇺🇸

Castro Valley, California, United States

Contra Costa Regional Medical Center

🇺🇸

Martinez, California, United States

East Bay Radiation Oncology Center

🇺🇸

Castro Valley, California, United States

Valley Medical Oncology

🇺🇸

Fremont, California, United States

Highland General Hospital

🇺🇸

Oakland, California, United States

Alta Bates Summit Medical Center - Summit Campus

🇺🇸

Oakland, California, United States

Epic Care - Oakland

🇺🇸

Oakland, California, United States

Bay Area Breast Surgeons, Incorporated

🇺🇸

Oakland, California, United States

Larry G Strieff MD Medical Corporation

🇺🇸

Oakland, California, United States

CCOP - Bay Area Tumor Institute

🇺🇸

Oakland, California, United States

Tom K Lee, Incorporated

🇺🇸

Oakland, California, United States

Doctors Medical Center - San Pablo Campus

🇺🇸

San Pablo, California, United States

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

🇺🇸

Hartford, Connecticut, United States

Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

🇺🇸

Boise, Idaho, United States

Mayo Clinic - Jacksonville

🇺🇸

Jacksonville, Florida, United States

St. Joseph Regional Medical Center

🇺🇸

Lewiston, Idaho, United States

Elkhart Clinic, LLC

🇺🇸

Elkhart, Indiana, United States

CCOP - Carle Cancer Center

🇺🇸

Urbana, Illinois, United States

Elkhart General Hospital

🇺🇸

Elkhart, Indiana, United States

Michiana Hematology-Oncology, PC - Elkhart

🇺🇸

Elkhart, Indiana, United States

Fort Wayne Medical Oncology and Hematology

🇺🇸

Fort Wayne, Indiana, United States

Howard Community Hospital

🇺🇸

Kokomo, Indiana, United States

Center for Cancer Therapy at LaPorte Hospital and Health Services

🇺🇸

La Porte, Indiana, United States

Saint Anthony Memorial Health Centers

🇺🇸

Michigan City, Indiana, United States

Michiana Hematology-Oncology, PC - South Bend

🇺🇸

Mishawaka, Indiana, United States

Saint Joseph Regional Medical Center

🇺🇸

Mishawaka, Indiana, United States

Michiana Hematology Oncology PC - Plymouth

🇺🇸

Plymouth, Indiana, United States

Memorial Hospital of South Bend

🇺🇸

South Bend, Indiana, United States

Michiana Hematology Oncology PC - La Porte

🇺🇸

Westville, Indiana, United States

Cedar Rapids Oncology Associates

🇺🇸

Cedar Rapids, Iowa, United States

Mercy Cancer Center - West Lakes

🇺🇸

Clive, Iowa, United States

Medical Oncology and Hematology Associates - West Des Moines

🇺🇸

Clive, Iowa, United States

Mercy Regional Cancer Center at Mercy Medical Center

🇺🇸

Cedar Rapids, Iowa, United States

Siouxland Hematology-Oncology Associates, LLP

🇺🇸

Sioux City, Iowa, United States

Mercy Medical Center - Sioux City

🇺🇸

Sioux City, Iowa, United States

St. Luke's Regional Medical Center

🇺🇸

Sioux City, Iowa, United States

Cancer Center of Kansas, PA - Dodge City

🇺🇸

Dodge City, Kansas, United States

Cancer Center of Kansas, PA - Chanute

🇺🇸

Chanute, Kansas, United States

Methodist West Hospital

🇺🇸

West Des Moines, Iowa, United States

Cancer Center of Kansas-Independence

🇺🇸

Independence, Kansas, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

York Hospital's Oncology Treatment Center

🇺🇸

York, Maine, United States

Greenebaum Cancer Center at University of Maryland Medical Center

🇺🇸

Baltimore, Maryland, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

🇺🇸

Baltimore, Maryland, United States

Hickman Cancer Center at Bixby Medical Center

🇺🇸

Adrian, Michigan, United States

Hurley Medical Center

🇺🇸

Flint, Michigan, United States

Green Bay Oncology, Limited - Escanaba

🇺🇸

Escanaba, Michigan, United States

Genesys Hurley Cancer Institute

🇺🇸

Flint, Michigan, United States

Oakwood Cancer Center at Oakwood Hospital and Medical Center

🇺🇸

Dearborn, Michigan, United States

Genesys Regional Medical Center

🇺🇸

Grand Blanc, Michigan, United States

Van Elslander Cancer Center at St. John Hospital and Medical Center

🇺🇸

Grosse Pointe Woods, Michigan, United States

Dickinson County Healthcare System

🇺🇸

Iron Mountain, Michigan, United States

Foote Memorial Hospital

🇺🇸

Jackson, Michigan, United States

Community Cancer Center of Monroe

🇺🇸

Monroe, Michigan, United States

Mercy Regional Cancer Center at Mercy Hospital

🇺🇸

Port Huron, Michigan, United States

Mercy Memorial Hospital - Monroe

🇺🇸

Monroe, Michigan, United States

St. Joseph Mercy Oakland

🇺🇸

Pontiac, Michigan, United States

Seton Cancer Institute at Saint Mary's - Saginaw

🇺🇸

Saginaw, Michigan, United States

St. John Macomb Hospital

🇺🇸

Warren, Michigan, United States

MeritCare Bemidji

🇺🇸

Bemidji, Minnesota, United States

Fairview Ridges Hospital

🇺🇸

Burnsville, Minnesota, United States

Mercy and Unity Cancer Center at Mercy Hospital

🇺🇸

Coon Rapids, Minnesota, United States

Fairview Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Mercy and Unity Cancer Center at Unity Hospital

🇺🇸

Fridley, Minnesota, United States

Minnesota Oncology - Maplewood

🇺🇸

Maplewood, Minnesota, United States

Hutchinson Area Health Care

🇺🇸

Hutchinson, Minnesota, United States

HealthEast Cancer Care at St. John's Hospital

🇺🇸

Maplewood, Minnesota, United States

New Ulm Medical Center

🇺🇸

New Ulm, Minnesota, United States

Humphrey Cancer Center at North Memorial Outpatient Center

🇺🇸

Robbinsdale, Minnesota, United States

Coborn Cancer Center

🇺🇸

Saint Cloud, Minnesota, United States

CentraCare Clinic - River Campus

🇺🇸

Saint Cloud, Minnesota, United States

CCOP - Metro-Minnesota

🇺🇸

Saint Louis Park, Minnesota, United States

United Hospital

🇺🇸

Saint Paul, Minnesota, United States

Park Nicollet Cancer Center

🇺🇸

Saint Louis Park, Minnesota, United States

Ridgeview Medical Center

🇺🇸

Waconia, Minnesota, United States

Willmar Cancer Center at Rice Memorial Hospital

🇺🇸

Willmar, Minnesota, United States

Regions Hospital Cancer Care Center

🇺🇸

St. Paul, Minnesota, United States

Lakeview Hospital

🇺🇸

Stillwater, Minnesota, United States

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis

🇺🇸

Saint Louis, Missouri, United States

Minnesota Oncology - Woodbury

🇺🇸

Woodbury, Minnesota, United States

Bozeman Deaconess Cancer Center

🇺🇸

Bozeman, Montana, United States

Montana Cancer Specialists at Montana Cancer Center

🇺🇸

Missoula, Montana, United States

Wayne Memorial Hospital, Incorporated

🇺🇸

Goldsboro, North Carolina, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Pardee Memorial Hospital

🇺🇸

Hendersonville, North Carolina, United States

Tucker Center for Cancer Care at Orange Regional Medical Center

🇺🇸

Middletown, New York, United States

FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center

🇺🇸

Pinehurst, North Carolina, United States

Mid Dakota Clinic, PC

🇺🇸

Bismarck, North Dakota, United States

MeritCare Broadway

🇺🇸

Fargo, North Dakota, United States

Roger Maris Cancer Center at MeritCare Hospital

🇺🇸

Fargo, North Dakota, United States

CCOP - MeritCare Hospital

🇺🇸

Fargo, North Dakota, United States

Wood County Oncology Center

🇺🇸

Bowling Green, Ohio, United States

Hematology Oncology Center

🇺🇸

Elyria, Ohio, United States

Lima Memorial Hospital

🇺🇸

Lima, Ohio, United States

Community Cancer Center

🇺🇸

Elyria, Ohio, United States

Northwest Ohio Oncology Center

🇺🇸

Maumee, Ohio, United States

Toledo Clinic - Oregon

🇺🇸

Oregon, Ohio, United States

St. Charles Mercy Hospital

🇺🇸

Oregon, Ohio, United States

North Coast Cancer Care, Incorporated

🇺🇸

Sandusky, Ohio, United States

Mercy Hospital of Tiffin

🇺🇸

Tiffin, Ohio, United States

Medical University of Ohio Cancer Center

🇺🇸

Toledo, Ohio, United States

Flower Hospital Cancer Center

🇺🇸

Sylvania, Ohio, United States

Toledo Hospital

🇺🇸

Toledo, Ohio, United States

St. Vincent Mercy Medical Center

🇺🇸

Toledo, Ohio, United States

CCOP - Toledo Community Hospital

🇺🇸

Toledo, Ohio, United States

St. Anne Mercy Hospital

🇺🇸

Toledo, Ohio, United States

Toledo Clinic, Incorporated - Main Clinic

🇺🇸

Toledo, Ohio, United States

Fulton County Health Center

🇺🇸

Wauseon, Ohio, United States

UPMC Cancer Centers

🇺🇸

Pittsburgh, Pennsylvania, United States

Sanford Cancer Center at Sanford USD Medical Center

🇺🇸

Sioux Falls, South Dakota, United States

Erlanger Cancer Center at Erlanger Hospital - Baroness

🇺🇸

Chattanooga, Tennessee, United States

Rapid City Regional Hospital

🇺🇸

Rapid City, South Dakota, United States

Fredericksburg Oncology, Incorporated

🇺🇸

Fredericksburg, Virginia, United States

Providence Centralia Hospital

🇺🇸

Centralia, Washington, United States

Overlake Cancer Center at Overlake Hospital Medical Center

🇺🇸

Bellevue, Washington, United States

Providence Regional Cancer Partnership

🇺🇸

Everett, Washington, United States

St. Francis Hospital

🇺🇸

Federal Way, Washington, United States

Allenmore Hospital

🇺🇸

Tacoma, Washington, United States

Providence St. Peter Hospital Regional Cancer Center

🇺🇸

Olympia, Washington, United States

MultiCare Regional Cancer Center at Tacoma General Hospital

🇺🇸

Tacoma, Washington, United States

Franciscan Cancer Center at St. Joseph Medical Center

🇺🇸

Tacoma, Washington, United States

Rockwood Clinic Cancer Treatment Center

🇺🇸

Spokane, Washington, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

Marshfield Clinic Cancer Care at Regional Cancer Center

🇺🇸

Eau Claire, Wisconsin, United States

St. Clare Hospital

🇺🇸

Tacoma, Washington, United States

Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center

🇺🇸

Green Bay, Wisconsin, United States

Green Bay Oncology, Limited at St. Mary's Hospital

🇺🇸

Green Bay, Wisconsin, United States

St. Mary's Hospital Medical Center - Green Bay

🇺🇸

Green Bay, Wisconsin, United States

St. Vincent Hospital Regional Cancer Center

🇺🇸

Green Bay, Wisconsin, United States

Holy Family Memorial Medical Center Cancer Care Center

🇺🇸

Manitowoc, Wisconsin, United States

Bay Area Cancer Care Center at Bay Area Medical Center

🇺🇸

Marinette, Wisconsin, United States

Marshfield Clinic - Marshfield Center

🇺🇸

Marshfield, Wisconsin, United States

Green Bay Oncology, Limited - Oconto Falls

🇺🇸

Oconto Falls, Wisconsin, United States

Marshfield Clinic - Indianhead Center

🇺🇸

Rice Lake, Wisconsin, United States

Marshfield Clinic - Lakeland Center

🇺🇸

Minocqua, Wisconsin, United States

Ministry Medical Group at Saint Mary's Hospital

🇺🇸

Rhinelander, Wisconsin, United States

Marshfield Clinic at Saint Michael's Hospital

🇺🇸

Stevens Point, Wisconsin, United States

St. Nicholas Hospital

🇺🇸

Sheboygan, Wisconsin, United States

Green Bay Oncology, Limited - Sturgeon Bay

🇺🇸

Sturgeon Bay, Wisconsin, United States

Marshfield Clinic - Weston Center

🇺🇸

Weston, Wisconsin, United States

Marshfield Clinic - Wisconsin Rapids Center

🇺🇸

Wisconsin Rapids, Wisconsin, United States

Welch Cancer Center at Sheridan Memorial Hospital

🇺🇸

Sheridan, Wyoming, United States

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Hennepin County Medical Center - Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

Cancer Center of Kansas, PA - Liberal

🇺🇸

Liberal, Kansas, United States

Cancer Center of Kansas, PA - Medical Arts Tower

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas, PA - El Dorado

🇺🇸

El Dorado, Kansas, United States

Via Christi Cancer Center at Via Christi Regional Medical Center

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas - Fort Scott

🇺🇸

Fort Scott, Kansas, United States

Cancer Center of Kansas, PA - Parsons

🇺🇸

Parsons, Kansas, United States

Cancer Center of Kansas, PA - Pratt

🇺🇸

Pratt, Kansas, United States

Cancer Center of Kansas, PA - McPherson

🇺🇸

McPherson, Kansas, United States

Associates in Womens Health, PA - North Review

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas, PA - Kingman

🇺🇸

Kingman, Kansas, United States

Cancer Center of Kansas, PA - Winfield

🇺🇸

Winfield, Kansas, United States

Rocky Mountain Oncology

🇺🇸

Casper, Wyoming, United States

Mayo Clinic Cancer Center

🇺🇸

Rochester, Minnesota, United States

St. Francis Cancer Center at St. Francis Medical Center

🇺🇸

Shakopee, Minnesota, United States

CCOP - Northern Indiana CR Consortium

🇺🇸

South Bend, Indiana, United States

Sparrow Regional Cancer Center

🇺🇸

Lansing, Michigan, United States

St. Mary Mercy Hospital

🇺🇸

Livonia, Michigan, United States

Saint Joseph Mercy Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

CCOP - Michigan Cancer Research Consortium

🇺🇸

Ann Arbor, Michigan, United States

St. James Healthcare Cancer Care

🇺🇸

Butte, Montana, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Hematology-Oncology Centers of the Northern Rockies - Billings

🇺🇸

Billings, Montana, United States

St. Peter's Hospital

🇺🇸

Helena, Montana, United States

Benefis Sletten Cancer Institute

🇺🇸

Great Falls, Montana, United States

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

🇺🇸

Missoula, Montana, United States

Billings Clinic - Downtown

🇺🇸

Billings, Montana, United States

CCOP - Iowa Oncology Research Association

🇺🇸

Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Methodist Medical Center

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at John Stoddard Cancer Center

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at Mercy Cancer Center

🇺🇸

Des Moines, Iowa, United States

Mercy Cancer Center at Mercy Medical Center - Des Moines

🇺🇸

Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Lutheran Hospital

🇺🇸

Des Moines, Iowa, United States

Ochsner Cancer Institute at Ochsner Clinic Foundation

🇺🇸

New Orleans, Louisiana, United States

Albert Einstein Cancer Center at Albert Einstein College of Medicine

🇺🇸

Bronx, New York, United States

Cancer Center of Kansas, PA - Wichita

🇺🇸

Wichita, Kansas, United States

St. Vincent Healthcare Cancer Care Services

🇺🇸

Billings, Montana, United States

Lakeland Regional Cancer Care Center - St. Joseph

🇺🇸

Saint Joseph, Michigan, United States

Lakeside Cancer Specialists, PLLC

🇺🇸

Saint Joseph, Michigan, United States

Lawrence Memorial Hospital

🇺🇸

Lawrence, Kansas, United States

Cancer Center of Kansas, PA - Newton

🇺🇸

Newton, Kansas, United States

Cancer Center of Kansas, PA - Wellington

🇺🇸

Wellington, Kansas, United States

Cancer Center of Kansas, PA - Salina

🇺🇸

Salina, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath